Overall, KW-2478 simultaneously inhibited the BCR/ABL and MAPK signalling pathways by disturbing the chaperone function of HSP90α and then induced obvious growth suppression in CML cells. This evidence concerns the gene HSP90AA1 and chronic myelogenous leukemia, BCR-ABL1 positive.